About the Authors
- Nathalie Compté
-
Affiliation Institute for Medical Immunology (IMI), Université Libre de Bruxelles, Charleroi, Belgium
- Karim Zouaoui Boudjeltia
-
Affiliation Experimental Medicine Laboratory (Unit 222), Université Libre de Bruxelles, Hôpital A. Vésale, Montigny-Le-Tilleul, Belgium
- Michel Vanhaeverbeek
-
Affiliation Experimental Medicine Laboratory (Unit 222), Université Libre de Bruxelles, Hôpital A. Vésale, Montigny-Le-Tilleul, Belgium
- Sandra De Breucker
-
Affiliation Service de Gériatrie, Hôpital Erasme, Bruxelles, Belgium
- Thierry Pepersack
-
Affiliation Service de Gériatrie, Hôpital Erasme, Bruxelles, Belgium
- Joel Tassignon
-
Affiliation ImmuneHealth, Charleroi, Belgium
- Anne Trelcat
-
Affiliation ImmuneHealth, Charleroi, Belgium
- Stanislas Goriely
-
* E-mail: stgoriel@ulb.ac.be
Affiliation Institute for Medical Immunology (IMI), Université Libre de Bruxelles, Charleroi, Belgium
Competing Interests
The study was partly supported GlaxoSmithKline Biologicals. Authors JT and AT are employed by ImmuneHealth, Charleroi, Belgium. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: NC TP KZB MV SG. Performed the experiments: NC AT. Analyzed the data: NC KZB MV SG. Contributed reagents/materials/analysis tools: NC SDB JT. Wrote the manuscript: NC TP MV SG.